Norkurarinol inhibits Toll-Like Receptor 3 (TLR3)-mediated pro-inflammatory signaling pathway and rotavirus replication

Journal of Pharmacological Sciences

Volumn 118, Issue 2, 2012, Pages 161-170

  Oh, Hyun Mee ^a   Lee, Seung Woong ^a   Park, Mi Hye ^a   Kim, Mi Hwa ^a   Ryu, Young Bae ^a   Kim, Myo Sun ^a   Kim, Ha Hyun ^a   Park, Ki Hun ^b   Lee, Woo Song ^a   Park, Su Jin ^a   Rho, Mun Chual ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

dsRNA; Inflammatory response; Norkurarinol; Rotavirus; Toll like receptor 3 (TLR3)

Indexed keywords

ALKALINE PHOSPHATASE; BETA INTERFERON; FLAVANONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NORKURARINOL; POLYINOSINIC POLYCYTIDYLIC ACID; SECRETED EMBRYONIC ALKALINE PHOSPHATASE; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; INFLAMMATION; ISOLATION PROCEDURE; NONHUMAN; PLANT ROOT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ROTAVIRUS; ROTAVIRUS INFECTION; SIGNAL TRANSDUCTION; SOPHORA; SOPHORA FLAVESCENS; VIRUS REPLICATION;

EID: 84863162808     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11077FP     Document Type: Article

References (38)

1. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376. (Pubitemid 37174535)
2. Tissari J, Siren J, Meri S, Julkunen I, Matikainen S. IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J Immunol. 2005;174:4289-4294. (Pubitemid 40396010)
3. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1-14.
4. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003;4:491-496. (Pubitemid 36592443)
5. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol. 2004;5: 503-507. (Pubitemid 38660462)
6. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor- 3, in the Toll-like receptor signaling. J Immunol. 2003; 171:4304-4310. (Pubitemid 37238709)
7. Youn HS, Saitoh SI, Miyake K, Hwang DH. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol. 2006;72:62-69. (Pubitemid 43810172)
8. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782-787.
9. Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, Kojima H, et al. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem. 2008;56:97-109. (Pubitemid 351170963)
10. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732-738. (Pubitemid 33009951)
11. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229:869-871. (Pubitemid 16246587)
12. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10:416-421. (Pubitemid 38508522)
13. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. Chest. 1991;99:169-175.
14. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol. 2005;174:131-142. (Pubitemid 40007399)
15. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3:768-780.
16. Youn HS, Lee JY, Saitoh SI, Miyake K, Hwang DH. Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochem Biophys Res Commun. 2006;350:866-871. (Pubitemid 44739925)
17. Jeong TS, Ryu YB, Kim HY, Curtis-Long MJ, An SJ, Lee JH, et al. Low density lipoprotein (LDL)-antioxidant flavonoids from roots of Sophora flavescens. Biol Pharm Bull. 2008;31:2097-2102.
18. Kim JH, Ryu YB, Kang NS, Lee BW, Heo JS, Jeong IY, et al. Glycosidase inhibitory flavonoids from Sophora flavescens. Biol Pharm Bull. 2006;29:302-305. (Pubitemid 43200901)
19. Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod. 1999;62:1595-1599. (Pubitemid 30030595)
20. Ryu YB, Curtis-Long MJ, Kim JH, Jeong SH, Yang MS, Lee KW, et al. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition. Bioorg Med Chem Lett. 2008;18:6046-6049.
21. Son JK, Park JS, Kim JA, Kim Y, Chung SR, Lee SH. Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity. Planta Med. 2003;69:559-561. (Pubitemid 36870635)
22. Barnard DL, Hill CL, Gage T, Matheson JE, Huffman JH, Sidwell RW, et al. Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antiviral Res. 1997;34:27-37. (Pubitemid 27132855)
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408. (Pubitemid 34164012)
24. Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin- 1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem. 2003;278:16713-16719. (Pubitemid 36799536)
25. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816-825.
26. Jiang B, Snipes-Magaldi L, Dennehy P, Keyserling H, Holman RC, Bresee J, et al. Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol. 2003;10:995-1001. (Pubitemid 37444264)
27. Yoneyama M, Suhara W, Fujita T. Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res. 2002;22:73-76. (Pubitemid 34161284)
28. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol. 2003;171:3154-3162. (Pubitemid 37093540)
29. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol. 2004;78:10213-10220. (Pubitemid 39258345)
30. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529-1531.
31. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526-1529. (Pubitemid 38314424)
32. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101:5598-5603. (Pubitemid 38481202)
33. Suo Z, Liu Y, Ferreri M, Zhang T, Liu Z, Mu X, et al. Impact of matrine on inflammation related factors in rat intestinal microvascular endothelial cells. J Ethnopharmacol. 2009;125:404-409.
34. Chen GY, Shiah HC, Su HJ, Chen CY, Chuang YJ, Lo WH, et al. Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway. J Virol. 2009;83:10548-10556.
35. Bagchi P, Dutta D, Chattopadhyay S, Mukherjee A, Halder UC, Sarkar S, et al. Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol. 2010;84:6834-6845.
36. Li K, Chen Z, Kato N, Gale M Jr, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005;280:16739-16747. (Pubitemid 41389131)
37. Spiegel M, Pichlmair A, Muhlberger E, Haller O, Weber F. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol. 2004;30:211-213. (Pubitemid 38622001)
38. Tak PP. IFN-beta in rheumatoid arthritis. Front Biosci. 2004; 9:3242-3247.